Donald T Moir

Title: The Innovative Contributions of Donald T. Moir

Introduction

Donald T. Moir is a notable inventor based in Concord, MA, with a significant impact in the field of biomedical research. He holds a total of four patents, showcasing his dedication to developing innovative solutions for pressing health challenges. His work primarily focuses on therapeutic advancements against viral and bacterial infections.

Latest Patents

One of his latest patents is titled "Broad spectrum inhibitors of filoviruses." This invention is related to the development of therapeutics and prophylactics for the treatment and prevention of filovirus infections in humans and other mammals. The patent discloses a new class of small molecules that inhibit the interaction of naturally processed filovirus glycoprotein with its host receptor Niemann-Pick C1 protein, effectively blocking the infection of host cells by filoviruses. Another significant patent is "Inhibitors of bacterial type III secretion system." This patent reveals organic compounds that inhibit effector toxin secretion or translocation mediated by bacterial type III secretion systems. These inhibitors are particularly useful for combating infections caused by Gram-negative bacteria.

Career Highlights

Throughout his career, Donald T. Moir has worked with various organizations, including Microbiotix, Inc. and Boston University. His contributions to these institutions have been instrumental in advancing research in infectious diseases and therapeutic development.

Collaborations

Donald has collaborated with notable colleagues such as John D. Williams and Daniel Aiello, further enhancing the scope and impact of his research endeavors.

Conclusion

Donald T. Moir's innovative work in developing inhibitors for viral and bacterial infections highlights his significant contributions to biomedical research. His patents reflect a commitment to improving health outcomes through scientific innovation.